Former Lexon UK director disqualified for role in nortriptyline competition law breach
A former director of Lexon UK has been disqualified for his involvement in the wholesaler’s “illegal information sharing” about the antidepressant nortriptyline, the Competition and Markets Authority (CMA) has announced.